Insights
Insights From Our Experts
Articles
Learning How to Play Dilution Dodgeball
The healthcare industry is reaching new heights in innovation, and as new drugs are founded, owners of biotech companies must decide whether or not they want to independently bring their product to market. Developing and successfully commercializing a…
Visualizing EVERSANA’s Omnichannel Activation Model
The pharma industry’s needs have evolved beyond one-dimensional playbooks, disconnected promotional efforts and limited ability to assess stakeholder engagement. Manufacturers need to adopt an omnichannel model that goes beyond “marketing” to provide actionable insights that better…
Pharmaceutical Opportunities and Challenges Facing Long-Term Care Facilities
Posted by
Dr. Richard Stefanacci on April 27, 20214/27/21
Skilled nursing facilities (SNF) and long-term care (LTC) facilities have been a major source for news stories throughout the COVID-19 pandemic due to the devastation brought to patient populations. Now, pharmaceutical manufacturers have an opportunity to…
Ask the Expert: How to Maximize Your Omnichannel Strategy
Omnichannel strategies are transforming the way consumers interact with brands across industries – from the all-in-one Magic Band experience at Disney to buying your favorite latte with the Starbucks app. The pharmaceutical industry is no exception,…
Webinar: Under Pressure: Global Trends in Net Price
In the past few years, net price transparency has become a subject of debate in the international pharma community. As pricing reforms and shifting pressures on pricing systems continue to intensify, how will they impact markets…
Expect More From Your Omnichannel Strategy and Investments
From ordering your daily Starbucks latte on your iPhone to skipping the line at Splash Mountain with your Disney Magic Band, omnichannel strategies transform how consumers interact with their favorite brands. The most successful brands create…
Five Trends That Will Shape the Current and Future Payer Market Landscape
As leading payers build new business models to ultimately advance their approaches to care and drug management, biopharmaceutical companies need to adjust their account engagement and drug access strategies accordingly. Here are a the top five…
Escaping the Chronic Microcap Trap: How Launching Alone Is the Only Option for Growth
As C-suite leaders in pharma wrestle with the pros and cons of launching alone, licensing or partnering with another company to launch their product, one factor they must consider is the impact their decision will have…
Turning Theory Into Action: How Real-World Evidence Drives Clinical Research and Improves Patient Outcomes
Life sciences companies have made significant investments in real-world data (RWD), but most established providers can deliver only a fraction of what’s needed to be impactful. Breaking down traditional healthcare silos for a more innovative approach…
BLOG: The ABCDs of Medicare Drug Coverage
Posted by
Dr. Richard Stefanacci on March 29, 20213/29/21
The Medicare benefit is divided into four parts, each providing a unique drug benefit. Together, the four parts provide medication coverage – from oral medications taken at home to IV treatments given in a physician’s office…